Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase 3 2Phase 2 2

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Sarcoma 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Kaposi 1Melanoma 1HIV Infections 1Adenoviridae Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Tumor Necrosis Factor-alpha × Clear all
NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed
32 enrolled

Adenoviridae Infections

NCT05222932 2025-08-07

AVENTIL

TILT Biotherapeutics Ltd.

Phase 1 Active not recruiting
15 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Melanoma

NCT00002262 2005-06-24

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 1 Completed
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡